Alder Therapeutics announced that it has received SEK 20 million in funding from Flerie Invest AB, Linc AB
Alder Therapeutics announced that it has received SEK 20 million in seed round of funding co-led by new investors Flerie Invest AB and Linc AB on September 27, 2022. Upon the completion, the company will receive an additional SEK 14.4 million co-investment, also equally split between Linc and Flerie Invest. Linc's and Flerie Invest's ownership will be 29% following the initial seed funding
round. Following the potential additional investment round the ownership would be 41%.